Advanced Wireless Sensors for Neonatal Care in the Delivery Room
Launched by GUILHERME SANT'ANNA, MD · Nov 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new advanced wireless sensor system designed to monitor the vital signs of healthy newborns right after they are born. The goal is to see if this wireless system works well compared to the traditional wired monitors currently used in hospitals. The study will look at how feasible, safe, and accurate the wireless sensors are for monitoring vital signs during the first two hours of the baby's life, while parents care for them in the delivery room.
To participate in this study, newborns must be at least 35 weeks old and stable at the time of delivery, meaning they are healthy and do not show any immediate medical concerns. Babies with skin issues or born before 35 weeks are not eligible. During the trial, each baby will have both types of monitoring devices placed on them, and their vital signs will be observed for two hours to gather important information about the new system's performance. This research could help improve how newborns are monitored in the future.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • 1. Newborns ≥35 weeks (gestational age)
- • 2. Newborns determined to be clinically stable at delivery
- • 3. Newborns with no skin abnormalities
- Exclusion criteria:
- • 1. Newborns ≤ 35 weeks (gestational age)
- • 2. Newborns determined to not be clinically stable at delivery
- • 3. Newborns with Skin abnormalities
About Guilherme Sant'anna, Md
Dr. Guilherme Sant'Anna, MD, is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a robust background in medicine and clinical practice, Dr. Sant'Anna leads innovative studies that focus on developing and evaluating new therapeutic interventions. His expertise spans various therapeutic areas, and he is dedicated to upholding the highest ethical standards in clinical research. Through collaborative partnerships with research institutions and a focus on patient-centered approaches, Dr. Sant'Anna aims to drive meaningful advancements in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Montréal, Quebec, Canada
Maputo, , Mozambique
Buenos Aires, , Argentina
Umuarama, Minas Gerais, Brazil
São Paulo, , Brazil
Harare, , Zimbabwe
Patients applied
Trial Officials
Guilherme Sant'Anna, MD, PhD
Principal Investigator
The Research institute of the McGill University Health Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported